Cigna Group (NYSE:CI - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a research note issued on Saturday, Wall Street Zen reports.
Other equities research analysts have also recently issued research reports about the company. UBS Group reissued a "buy" rating on shares of Cigna Group in a research note on Thursday, October 1st. Robert W. Baird set a $362.00 price target on Cigna Group in a research note on Friday, July 31st. Cantor Fitzgerald reiterated an "overweight" rating and set a $340.00 price target on shares of Cigna Group in a report on Friday, November 6th. Weiss Ratings reissued a "hold (c)" rating on shares of Cigna Group in a research report on Thursday, August 27th. Finally, Piper Sandler reduced their price objective on shares of Cigna Group from $370.00 to $360.00 and set an "overweight" rating on the stock in a report on Thursday, November 12th. Fourteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, Cigna Group presently has an average rating of "Moderate Buy" and a consensus target price of $337.35.
Read Our Latest Report on Cigna Group
Cigna Group Stock Performance
NYSE:CI opened at $270.83 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The firm has a market capitalization of $71.36 billion, a price-to-earnings ratio of 9.49, a PEG ratio of 1.12 and a beta of 0.25. The company's 50-day moving average is $288.03 and its two-hundred day moving average is $282.99. Cigna Group has a 1-year low of $257.85 and a 1-year high of $318.05.
Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.52 by $0.46. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The business had revenue of $73.79 billion during the quarter, compared to the consensus estimate of $72.64 billion. During the same quarter last year, the firm earned $7.83 EPS. The business's revenue was up 5.6% compared to the same quarter last year. Analysts forecast that Cigna Group will post 30.70 EPS for the current year.
Insider Activity at Cigna Group
In other news, insider Everett Neville sold 617 shares of the firm's stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares in the company, valued at $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Cigna Group
Several hedge funds have recently bought and sold shares of the company. Mystic Asset Management Inc. acquired a new stake in shares of Cigna Group in the second quarter valued at $2,808,000. KBC Group NV grew its stake in Cigna Group by 6.4% during the 2nd quarter. KBC Group NV now owns 380,034 shares of the health services provider's stock worth $104,768,000 after purchasing an additional 22,978 shares in the last quarter. Nykredit A S acquired a new position in Cigna Group during the 2nd quarter worth $15,300,000. Sanctuary Advisors LLC purchased a new stake in Cigna Group during the 2nd quarter worth about $11,043,000. Finally, TD Asset Management Inc increased its holdings in Cigna Group by 4.8% during the 2nd quarter. TD Asset Management Inc now owns 249,966 shares of the health services provider's stock worth $68,911,000 after purchasing an additional 11,471 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.
Cigna Group News Summary
Here's some of the latest news about CI:
- Positive Sentiment: A recent article raises the possibility that CI is undervalued following management’s UBS Healthcare Conference update, though the supplied article details do not specify the basis for that assessment. Cigna valuation discussion
- Neutral Sentiment: The Cigna Group Foundation announced $31.5 million in grants for community organizations across 10 states, supporting youth mental health, veterans, and people with complex health conditions. The announcement highlights community investment but provides no direct financial outlook update. Cigna Foundation grants
- Negative Sentiment: A proposed CMS rule would expand fraud oversight and reporting requirements across government health programs, raising regulatory and repayment concerns for managed-care stocks. Cigna sold its Medicare Advantage and Part D businesses in 2025, suggesting some of the pressure may reflect sector-wide sentiment rather than direct exposure. CMS rule and managed-care stocks
About Cigna Group
(
Get Free Report)
The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.